US$ 27.61
aod9604 dosing protocol December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting Peptide Information Sheet, Protocol Guide,
Description
Topical serums typically contain 1-3% GHK-Cu concentration

5-Amino-1MQ Side Effects & Safety 5-Amino-1MQ has no published human safety trial

Best published PK (Awosemo et al., 2021, rats): ~38% oral bioavailability, ~6 to 7 hr oral half-life

The Phase 2 trial is the only controlled human efficacy study
